SuperworthSynopsys SNPS
- Market cap
- $82.4B
- PE
- 76.0×
- 10y median 54.3×
- Forward PE
- 24.5×
- 10y median 32.1×
- Price to sales
- 8.8×
- EV/EBIT
- 84.7×
- Revenue, 12 months
- $9.4B
- +46% on a year ago
- Net margin
- 11.4%
- Free cash flow yield
- 3.3%
Synopsys trades at 76.0× trailing earnings, pricier than 84% of the last ten years. Revenue was $9.4B over the last twelve months, up 46% on a year earlier with a 11% net margin.
Charts
Financials
| Income statement | Q4 FY23 | Q1 FY24 | Q2 FY24 | Q3 FY24 | Q4 FY24 | Q1 FY25 | Q2 FY25 | Q3 FY25 | Q4 FY25 | Q1 FY26 | Q2 FY26 | Q3 FY26 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| $1.6B+25% | $1.5B+11% | $1.5B+15% | $1.5B+13% | $1.6B+2% | $1.5B−4% | $1.6B+10% | $1.7B+14% | $2.3B+38% | $2.4B+66% | $2.3B+42% | $2.5B+42% | |
| Cost of revenue | $332.3M+18% | $279.2M−2% | $300.4M+21% | $290.7M+12% | $375M+13% | $270M−3% | $318.3M+6% | $380.6M+31% | $654.7M+75% | $637.4M+136% | $629.9M+98% | $679.4M+79% |
| Gross profit | $1.3B+27% | $1.2B+14% | $1.2B+14% | $1.2B+13% | $1.3B−1% | $1.2B−4% | $1.3B+11% | $1.4B+10% | $1.6B+27% | $1.8B+49% | $1.6B+28% | $1.8B+32% |
| R&D | $488.5M+6% | $525.5M+13% | $493.1M+7% | $508.9M+5% | $554.8M+14% | $553.2M+5% | $554M+12% | $625.3M+23% | $746.8M+35% | $715M+29% | $700.1M+26% | $719.7M+15% |
| SG&A | $341.1M+8% | $350.1M+14% | $324.5M+22% | $361.9M+27% | $391.3M+15% | $376.3M+8% | $351.5M+8% | $540M+49% | $576M+47% | $579.1M+54% | $554.4M+58% | $562.9M+4% |
| $424.2M+95% | $352.6M+38% | $332.1M+14% | $360.2M+20% | $310.8M−27% | $251.8M−29% | $376.4M+13% | $165.3M−54% | $121.4M−61% | $203M−19% | $120.4M−68% | $357.5M+116% | |
| Interest expense | $260K−28% | $1.3M+402% | $7.1M+2165% | $11.7M+3333% | $16.3M+6162% | $11.1M+741% | $94.3M+1235% | $146.5M+1148% | $194.8M+1096% | $162.7M+1361% | $133.4M+41% | $133.2M−9% |
| Pre-tax income | $403.8M+90% | $457.5M+64% | $341.5M+15% | $392M+20% | $322.9M−20% | $291.1M−36% | $396.2M+16% | $189.3M−52% | $516.5M+60% | $79.1M−73% | $19.3M−95% | $683.9M+261% |
| $63.2M+4% | $22.9M+116% | $45.4M+90% | −$30.7M+342% | $62.1M−2% | −$6.3M | $47.2M+4% | −$53M+73% | $68.1M+10% | $14.3M | $2.4M−95% | $138.2M | |
| Net income | $349.2M+128% | $449.1M+65% | $292.1M+7% | $408.1M+21% | $1.1B+219% | $295.7M−34% | $345.3M+18% | $242.5M−41% | $448.7M−60% | $65M−78% | $17.1M−95% | $545.8M+125% |
| $2.25+130% | $2.89+65% | $1.88+7% | $2.61+20% | $7.13+217% | $1.89−35% | $2.21+18% | $1.50−43% | $2.39−67% | $0.34−82% | $0.09−96% | $2.84+89% | |
| 155.4M−1% | 155.3M+0% | 155.8M+1% | 156.1M+1% | 156.2M+1% | 156.2M+1% | 156.1M+0% | 161.7M+4% | 187.9M+20% | 190.8M+22% | 192.1M+23% | 192.3M+19% |
EPS, diluted: 16 periods, Q4 FY09 to Q4 FY25: quarter's net income to common over its shares, to the cent.
Diluted shares: 16 periods, Q4 FY09 to Q4 FY25: share-days: the 12-month average less the 9-month, weighted by days. Q4 FY17: a loss quarter: its basic count, share-days: the 12-month average less the 9-month, weighted by days.
From each company's 10-Q and 10-K filings, the newest version of each figure. Quarters are as filed (a fourth quarter is the year less its first nine months), fiscal years as the 10-K prints them, restated where a later 10-K restated them, and balance sheet lines as of the period's end. A quarter whose 10-Q isn't filed yet is from the company's results release. Growth is on the same period a year earlier. A dash is a period with no figure for the line: the filing doesn't print it, or it hasn't been read yet.
Estimates
Next earnings report: .
| Quarter | Revenue | Range | EPS | Range | Analysts |
|---|---|---|---|---|---|
| Q4 FY26 | $2.6B | $2.5B to $2.6B | $4.12 | $4.02 to $4.15 | 11 |
| Q1 FY27 | $2.7B | $2.6B to $2.8B | $4.47 | $4.10 to $4.95 | 8 |
| Q2 FY27 | $2.6B | $2.5B to $2.7B | $4.25 | $4.07 to $4.48 | 4 |
| Q3 FY27 | $2.8B | $2.7B to $2.9B | $4.78 | $4.58 to $5.03 | 3 |
| Q4 FY27 | $3B | $2.9B to $3.1B | $5.20 | $4.98 to $5.48 | 5 |
| Q1 FY28 | $3B | $2.9B to $3.2B | $5.54 | $5.30 to $5.83 | 4 |
| Q2 FY28 | $3B | $2.9B to $3.1B | $5.44 | $5.21 to $5.73 | 5 |
| Q3 FY28 | $3.2B | $3.1B to $3.3B | $5.95 | $5.70 to $6.26 | 4 |
Peers
Companies in Software - Infrastructure nearest Synopsys' size, closest first.
| Company | Market cap | PE | Its 10y median PE | Fwd PE | P/S | Revenue growth | Net margin |
|---|---|---|---|---|---|---|---|
| SNPSSynopsys | $82.4B | 76.0× | 54.3× | 24.5× | 8.8× | +46% | 11.4% |
| NETCloudflare | $116B | n/m | n/a | 220× | 46.2× | +34% | −8.2% |
| FTNTFortinet | $132.1B | 63.4× | 56.4× | 51.1× | 17.5× | +19% | 28.2% |
| XYZBlock | $45.9B | 137× | 82.4× | 16.7× | 1.8× | +5% | 1.4% |
| ZSZscaler | $41.6B | n/m | n/a | 52.3× | 12.4× | +25% | −1.9% |
| TWLOTwilio | $40.2B | 36.5× | 299× | 42.3× | 7.2× | +18% | 20.6% |
| OKTAOkta | $37.2B | 128× | 100× | 52.2× | 12.1× | +11% | 9.6% |
| MDBMongoDB | $29.9B | n/m | n/a | 53.0× | 10.7× | +25% | 2.1% |
| VRSNVeriSign | $27.1B | 32.6× | 30.7× | 29.1× | 15.9× | +7% | 49.8% |
| CPAYCorpay | $26.8B | 24.9× | 24.5× | 13.9× | 5.3× | +20% | 22.7% |
| RBRKRubrik | $26.7B | n/m | n/a | 265× | 17.3× | +42% | −16.5% |
| Peer median | $38.7B | 49.9× | 69.4× | 51.6× | 12.3× | +20% | 5.9% |
Investors who own it
Investors we follow who held Synopsys at the end of Jun 30, 2026, from their 13F filings.
- Paul SingerElliott Investment Management0.7% of portfolionew
- Brad GerstnerAltimeter Capital0.6% of portfolionew
- Philippe LaffontCoatue Management0.3% of portfoliotrimmed
- Cathie WoodARK Investment Management0.2% of portfolioadded
- Polen CapitalPolen Capital0.2% of portfoliotrimmed
- Ron BaronBaron Capital0.0% of portfoliotrimmed
More on Synopsys
Each number over time
- PE ratio
- Forward PE
- Price to sales ratio
- EV/EBIT
- Price to free cash flow
- Price to book ratio
- Market cap
- Revenue
- EPS
- Free cash flow
- Profit margin
- Shares outstanding
Where it ranks
- #6of 141Infrastructure software stocks with the fastest revenue growth
- #5of 17Infrastructure software stocks with the lowest PEG ratio
- #7of 21Infrastructure software stocks with the lowest forward PE
Its groups
About
- Industry
- Software - Infrastructure
- Sector
- Technology
Valuation data, not investment advice. Prices as of .